TY - JOUR
T1 - Occurrence and impact of pelvic floor dysfunction in women with and without breast cancer
T2 - a cross-sectional study
AU - Colombage, Udari N.
AU - Soh, Sze Ee
AU - Lin, Kuan Yin
AU - White, Michelle
AU - Vincent, Amanda
AU - Fox, Jane
AU - Frawley, Helena C.
N1 - Publisher Copyright:
© 2022 Associação Brasileira de Pesquisa e Pós-Graduação em Fisioterapia
PY - 2022/11
Y1 - 2022/11
N2 - Background: One of the sequalae of breast cancer treatments may be pelvic floor (PF) dysfunction such as urinary incontinence (UI), faecal incontinence (FI), and pelvic organ prolapse (POP). Objective: The aim of this study was to compare the occurrence and related distress and impact of PF dysfunction between women with and without breast cancer. Methods: Women with and without breast cancer participated in this cross-sectional study. The Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire were used to quantify the prevalence and related distress, and impact of PF dysfunction. Factors associated with PF outcomes were examined using logistic and linear regressions while controlling for known risk factors for PF dysfunction (age, body mass index, and parity). Results: 120 women with breast cancer, and 170 women without breast cancer responded. The occurrence of any type of UI was higher in women with breast cancer than women without breast cancer (percentage difference=17%; 95% CI: 7, 29). Women with breast cancer experienced higher impact of urinary symptoms (mean difference=18.2; 95% CI: 8.9, 27.7) compared to those without. Multivariable analysis indicated that having breast cancer (β 0.33; 95%CI: 0.08, 0.51) was the strongest predictor of greater impact of urinary symptoms. Conclusion: Women with breast cancer reported a higher occurrence and impact of urinary symptoms than women without breast cancer. While further studies are required to confirm our findings, routine screening and offering treatment for urinary symptoms may be indicated for women with breast cancer.
AB - Background: One of the sequalae of breast cancer treatments may be pelvic floor (PF) dysfunction such as urinary incontinence (UI), faecal incontinence (FI), and pelvic organ prolapse (POP). Objective: The aim of this study was to compare the occurrence and related distress and impact of PF dysfunction between women with and without breast cancer. Methods: Women with and without breast cancer participated in this cross-sectional study. The Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire were used to quantify the prevalence and related distress, and impact of PF dysfunction. Factors associated with PF outcomes were examined using logistic and linear regressions while controlling for known risk factors for PF dysfunction (age, body mass index, and parity). Results: 120 women with breast cancer, and 170 women without breast cancer responded. The occurrence of any type of UI was higher in women with breast cancer than women without breast cancer (percentage difference=17%; 95% CI: 7, 29). Women with breast cancer experienced higher impact of urinary symptoms (mean difference=18.2; 95% CI: 8.9, 27.7) compared to those without. Multivariable analysis indicated that having breast cancer (β 0.33; 95%CI: 0.08, 0.51) was the strongest predictor of greater impact of urinary symptoms. Conclusion: Women with breast cancer reported a higher occurrence and impact of urinary symptoms than women without breast cancer. While further studies are required to confirm our findings, routine screening and offering treatment for urinary symptoms may be indicated for women with breast cancer.
KW - Breast cancer
KW - Distress
KW - Impact
KW - Prevalence
KW - Urinary incontinence
UR - http://www.scopus.com/inward/record.url?scp=85140295734&partnerID=8YFLogxK
U2 - 10.1016/j.bjpt.2022.100455
DO - 10.1016/j.bjpt.2022.100455
M3 - Article
C2 - 36283252
AN - SCOPUS:85140295734
SN - 1413-3555
VL - 26
JO - Brazilian Journal of Physical Therapy
JF - Brazilian Journal of Physical Therapy
IS - 6
M1 - 100455
ER -